Home/Filings/4/0001209191-17-002458
4//SEC Filing

AMICUS THERAPEUTICS INC 4

Accession 0001209191-17-002458

$FOLDCIK 0001178879operating

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 9:27 PM ET

Size

7.1 KB

Accession

0001209191-17-002458

Insider Transaction Report

Form 4
Period: 2017-01-03
Andrews Kurt J.
SVP, Human Resources
Transactions
  • Award

    Stock Options (right to buy)

    2017-01-03+42,37242,372 total
    Exercise: $5.13Exp: 2027-01-03Common Stock (42,372 underlying)
  • Award

    Common Stock

    2017-01-03+30,48734,737 total
Footnotes (1)
  • [F1]These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on January 3, 2018. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on February 1, 2018, with the final installment vesting on January 1, 2021.

Issuer

AMICUS THERAPEUTICS INC

CIK 0001178879

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001178879

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 9:27 PM ET
Size
7.1 KB